|
The Technology
Augurex’s lead technology, AGX-020 is a novel biomarker of arthritis. It is a
protein that is normally present inside of cells but in people with arthritis it is released into the
joints and causes harmful molecules to breakdown joint tissue. Scientists have found that it is not only present in the joints of arthritis patients
but that it is measurable in blood which makes this protein particularly useful for diagnosing arthritis
and following patients for disease progression through a simple blood test.
|
